Joshua Pinto
Insider Reports History
- Location
- Watertown, MA
- Signature
- /s/ Michael Milligan, as Attorney-in-Fact for Joshua Pinto
- All insider transactions
- Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date
Holdings reported by Joshua Pinto:
| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Neumora Therapeutics, Inc. | President | Common Stock | 152,167 | $310,420 | $2.04 | 17 Feb 2026 | Indirect |
| Neumora Therapeutics, Inc. | President | Common Stock | 57,783 | $204,262 | $3.54 | 17 Feb 2026 | Direct |
| Metsera, Inc. | Director | Common Stock | 0 | $0 | $52.33 | 13 Nov 2025 | Direct |
| Neumora Therapeutics, Inc. | President | Stock Option (Right to Buy) | 1,200,000 | 08 Jan 2026 | Direct | ||
| Metsera, Inc. | Director | Restricted Stock Unit | 2,688 | 13 Nov 2025 | Direct | ||
| Metsera, Inc. | Director | Stock Option (right to buy) | 0 | 13 Nov 2025 | By LLC | ||
| Metsera, Inc. | Director | Stock Option (right to buy) | 0 | 13 Nov 2025 | Direct |
Insider Reports Filed by Joshua Pinto
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| NMRA | Neumora Therapeutics, Inc. | 17 Feb 2026 | 1 | -$21,093 | 4 | President | 19 Feb 2026, 17:06 |
| NMRA | Neumora Therapeutics, Inc. | 08 Jan 2026 | 1 | $0 | 4 | President | 09 Jan 2026, 16:18 |
| MTSR | Metsera, Inc. | 13 Nov 2025 | 4 | $0 | 4 | Director | 13 Nov 2025, 21:00 |
| NMRA | Neumora Therapeutics, Inc. | 28 May 2025 | 14 | $0 | 4 | President | 30 May 2025, 18:25 |
| NMRA | Neumora Therapeutics, Inc. | 21 May 2025 | 2 | $0 | 4 | President | 23 May 2025, 16:42 |
| MTSR | Metsera, Inc. | 20 May 2025 | 3 | $0 | 4 | Director | 22 May 2025, 19:42 |
| NMRA | Neumora Therapeutics, Inc. | 18 Feb 2025 | 1 | -$13,477 | 4 | President | 20 Feb 2025, 17:11 |
| NMRA | Neumora Therapeutics, Inc. | 13 Feb 2025 | 13 | $0 | 4 | President | 18 Feb 2025, 16:30 |
| MTSR | Metsera, Inc. | 30 Jan 2025 | 0 | $0 | 3 | Director | 30 Jan 2025, 21:28 |
| NMRA | Neumora Therapeutics, Inc. | 27 Aug 2024 | 1 | -$178,806 | 4 | Chief Financial Officer | 27 Aug 2024, 17:58 |
| NMRA | Neumora Therapeutics, Inc. | 22 Aug 2024 | 3 | -$984,061 | 4 | Chief Financial Officer | 26 Aug 2024, 18:17 |
| NMRA | Neumora Therapeutics, Inc. | 17 Apr 2024 | 1 | $0 | 4 | Chief Financial Officer | 28 Jun 2024, 21:00 |
| NMRA | Neumora Therapeutics, Inc. | 14 Feb 2024 | 2 | $0 | 4 | Chief Financial Officer | 16 Feb 2024, 16:21 |
| NMRA | Neumora Therapeutics, Inc. | 14 Sep 2023 | 0 | $0 | 3 | Chief Financial Officer | 14 Sep 2023, 18:52 |